These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 19577811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H, Cudrici C, Niculescu F, Shin ML.
    J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199
    [Abstract] [Full Text] [Related]

  • 3. C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection.
    Rus H, Cudrici C, Niculescu F.
    Ann Med; 2005 Nov; 37(2):97-104. PubMed ID: 16026117
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
    Loda E, Balabanov R.
    Rev Neurosci; 2012 Jan 26; 23(2):145-52. PubMed ID: 22499673
    [Abstract] [Full Text] [Related]

  • 8. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 26; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis.
    LeVine SM, Chakrabarty A.
    Ann N Y Acad Sci; 2004 Mar 26; 1012():252-66. PubMed ID: 15105271
    [Abstract] [Full Text] [Related]

  • 15. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
    Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, Ffrench-Constant C, Franklin RJ, Hoekstra D, Zhao C, Baron W.
    Brain; 2013 Jan 26; 136(Pt 1):116-31. PubMed ID: 23365094
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
    Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH.
    Exp Neurol; 2009 Nov 26; 220(1):44-56. PubMed ID: 19616545
    [Abstract] [Full Text] [Related]

  • 17. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H.
    Ann Neurol; 1998 Apr 26; 43(4):465-71. PubMed ID: 9546327
    [Abstract] [Full Text] [Related]

  • 18. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Apr 26; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S.
    Neurology; 2007 May 29; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [Abstract] [Full Text] [Related]

  • 20. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.
    Liu Y, Given KS, Harlow DE, Matschulat AM, Macklin WB, Bennett JL, Owens GP.
    Acta Neuropathol Commun; 2017 Mar 24; 5(1):25. PubMed ID: 28340598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.